157 related articles for article (PubMed ID: 36836779)
1. In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers.
Kaddoura R; Alqutami F; Asbaita M; Hachim M
Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836779
[TBL] [Abstract][Full Text] [Related]
2. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
[TBL] [Abstract][Full Text] [Related]
4. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract][Full Text] [Related]
5. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
[TBL] [Abstract][Full Text] [Related]
6. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer.
Bissanum R; Kamolphiwong R; Navakanitworakul R; Kanokwiroon K
Transl Cancer Res; 2022 Sep; 11(9):3039-3049. PubMed ID: 36237261
[TBL] [Abstract][Full Text] [Related]
8. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
[TBL] [Abstract][Full Text] [Related]
9. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
Zhong G; Lou W; Shen Q; Yu K; Zheng Y
Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer.
Chen B; Tang H; Chen X; Zhang G; Wang Y; Xie X; Liao N
Cancer Manag Res; 2019; 11():179-190. PubMed ID: 30613165
[TBL] [Abstract][Full Text] [Related]
11. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
[TBL] [Abstract][Full Text] [Related]
12. Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer.
Wang Y; Li H; Ma J; Fang T; Li X; Liu J; Afewerky HK; Li X; Gao Q
Onco Targets Ther; 2019; 12():8401-8410. PubMed ID: 31632087
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
Yuan Q; Zheng L; Liao Y; Wu G
World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
[TBL] [Abstract][Full Text] [Related]
14. RNA-sequencing and microarray data mining revealing: the aberrantly expressed mRNAs were related with a poor outcome in the triple negative breast cancer patients.
Fei H; Chen S; Xu C
Ann Transl Med; 2020 Mar; 8(6):363. PubMed ID: 32355807
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel prognostic genes of triple-negative breast cancer using meta-analysis and weighted gene co-expressed network analysis.
Cao W; Jiang Y; Ji X; Guan X; Lin Q; Ma L
Ann Transl Med; 2021 Feb; 9(3):205. PubMed ID: 33708832
[TBL] [Abstract][Full Text] [Related]
16. Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis.
He J; Yang J; Chen W; Wu H; Yuan Z; Wang K; Li G; Sun J; Yu L
PLoS One; 2015; 10(6):e0129842. PubMed ID: 26103053
[TBL] [Abstract][Full Text] [Related]
17. Identification of hub genes in triple-negative breast cancer by integrated bioinformatics analysis.
Wei LM; Li XY; Wang ZM; Wang YK; Yao G; Fan JH; Wang XS
Gland Surg; 2021 Feb; 10(2):799-806. PubMed ID: 33708561
[TBL] [Abstract][Full Text] [Related]
18. An
de Bastos DR; Conceição MPF; Michelli APP; Leite JMRS; da Silva RA; Cintra RC; Sanchez JJD; Vilanova-Costa CAST; Silva AMTC
Eur J Breast Health; 2021 Jan; 17(1):42-52. PubMed ID: 33796830
[TBL] [Abstract][Full Text] [Related]
19. Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer.
Yi J; Zhong W; Wu H; Feng J; Zouxu X; Huang X; Li S; Shuang Z
Front Oncol; 2021; 11():746058. PubMed ID: 34745969
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers.
Limsakul P; Choochuen P; Charupanit G; Charupanit K
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
